Dr. Stephen Robbins has been appointed Director of the Lady Davis Institute, effective January 2021.
The elderly are especially prone to depression during the COVID-19 lockdown. That’s why the Telehealth Intervention Program for Isolated Older Adults is providing emotional support.
The Online Health Information Aid has been developped to provide advice on conducting better online searches, evaluating the trustworthiness of websites, and using information effectively.
The Segal Cancer Centre at the JGH has responded to COVID-19 with compassion and innovation by enabling patients can consult with oncologists by video as an alternative to face-to-face meetings.
As the proportion of seniors in our population steadily rises, so will the need for geriatric psychiatry, says Dr. Soham Rej, a CIUSSS psychiatrist. He believes digital technology can help cope with the growing demand, but only if the human element remains intact.
Several types of fatal pediatric brain tumours originate during early brain development, Dr. Claudia Kleinman, of the Lady Davis Institute, and her collaborators have discovered. The genetic event that triggers the disease probably occurs in prenatal cellular development.
Dr. David Langleben, a researcher and JGH cardiologist, has determined that only a portion of available capillary capacity is used during normal physical activity, with a reserve function recruited as needed. This resolves an old question about blood flow during exercise.
Dr. Gerald Batist, Director of the Segal Cancer Centre and Deputy Director of the Lady Davis Institute at the JGH, has received the 2019 Award for Exceptional Leadership in Cancer Research from the Canadian Cancer Research Alliance.
Dr. Michael Pollak, Director of the Stroll Cancer Prevention Centre at the JGH, has been chosen to serve as one of two leaders of a new Canada-wide team, aimed at translating fundamental research about breast cancer into effective treatment options for patients.
A ground-breaking new study has succeeded in compiling an “atlas” of genetic factors that are associated with estimated bone mineral density, one of the most clinically relevant factors in diagnosing osteoporosis.